Cystic fibrosis registry: A preliminary report of CF patient from NRITLD

S. Khalilzadeh, M.R. Bloorsaz, N. Baghaie, E. Heydarian Fard, M. Hassanzad (Tehran, Islamic Republic Of Iran)

Source: Annual Congress 2012 - Cystic fibrosis (adults and children): risk factors and clinical problems
Session: Cystic fibrosis (adults and children): risk factors and clinical problems
Session type: Thematic Poster Session
Number: 1111
Disease area: Interstitial lung diseases, Paediatric lung diseases, Respiratory infections

Congress or journal article abstract

Rating: 0
You must login to grade this presentation.

Share or cite this content

Citations should be made in the following way:
S. Khalilzadeh, M.R. Bloorsaz, N. Baghaie, E. Heydarian Fard, M. Hassanzad (Tehran, Islamic Republic Of Iran). Cystic fibrosis registry: A preliminary report of CF patient from NRITLD. Eur Respir J 2012; 40: Suppl. 56, 1111

You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.

Member's Comments

No comment yet.
You must Login to comment this presentation.


Related content which might interest you:
National survey of hearing assessment in patients with cystic fibrosis in the UK
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


Cystic fibrosis year in review
Source: Annual Congress 2007 - Paediatric year in review
Year: 2007


Case study in cystic fibrosis: the US CF Foundation research and clinical development programmes
Source: Research Seminar 2014 - Breaking down barriers to lung health: a better environment for better medicines
Year: 2014


Cystic fibrosis: paediatric
Source: ERS Skills Course 2017 - Summer school of adult respiratory medicine
Year: 2017

Cystic fibrosis: paediatric
Source: ERS Course 2018 - Summer school of adult respiratory medicine
Year: 2018

Cystic fibrosis: paediatric
Source: ERS Course 2019 - Summer school of adult respiratory medicine
Year: 2019

Cystic fibrosis: paediatric
Source: ERS Skills Course 2016
Year: 2016

Evidence incidence of cystic fibrosis: A 30-year study in Krasnoyarsk, Russia
Source: Annual Congress 2013 –Cystic fibrosis: clinical problems, genetics and microbiology in children
Year: 2013

The Russian registry of cystic fibrosis
Source: Eur Respir J 2007; 30: Suppl. 51, 397s
Year: 2007

Cystic fibrosis diagnosis in adulthood as a result of study of relatives within the newborn screening programme
Source: International Congress 2015 – Cystic fibrosis: assessment and treatment
Year: 2015


Lung transplantation for Non- Cystic fibrosis bronchiectasis: A single centre retrospective analysis of 34 patients
Source: International Congress 2015 – Outcomes of lung transplantation
Year: 2015

Cystic fibrosis heelprick among a newborn population in the Netherlands: the CHOPIN study
Source: Annual Congress 2009 - Cystic fibrosis: disease progression and novel therapies
Year: 2009


Annual change of LCI among patients with cystic fibrosis
Source: International Congress 2016 – Cystic fibrosis: monitoring and management
Year: 2016

Risk of asthma in heterozygous carriers for cystic fibrosis: A meta-analysis
Source: International Congress 2016 – Cystic fibrosis: various aspects
Year: 2016


Modelling future trends in cystic fibrosis demography using the French Cystic Fibrosis Registry: update and sensitivity analysis
Source: Eur Respir J, 50 (2) 1700763; 10.1183/13993003.00763-2017
Year: 2017



Clinical, functional and microbiological characteristics of an adult brazilian cystic fibrosis population
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


Lung MRI findings in children with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014

Clinical value of lung clearance index (LCI) among patients with cystic fibrosis
Source: International Congress 2014 – Cystic fibrosis: clinical assessment and treatment
Year: 2014


The changing epidemiology of cystic fibrosis in Italy: data from the Italian registry
Source: Eur Respir J 2002; 20: Suppl. 38, 340s
Year: 2002

Retrospective analysis of treatment with Ivacaftor/Lumacaftor in patients with cystic fibrosis at the Munich Cystic Fibrosis Centers
Source: International Congress 2018 – Latest developments in cystic fibrosis
Year: 2018